ZIG
BSX icon

Zurich Insurance Group’s Boston Scientific BSX Stock Holding History

Zurich Insurance Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-272,168
Closed -$17.1M – 330
2026
Q1 		$17.1M Buy
+272,168
New +$21.8M 0.13% 177
2025
Q3 		– Sell
-1,208,040
Closed -$130M – 278
2025
Q2 		$130M Sell
1,208,040
-172,766
-13% -$17.5M 1% 25
2025
Q1 		$139M Sell
1,380,806
-381,406
-22% -$38.4M 1.13% 18
2024
Q4 		$157M Buy
1,762,212
+268,820
+18% +$23.7M 1.28% 15
2024
Q3 		$125M Sell
1,493,392
-554,318
-27% -$43.7M 1.06% 21
2024
Q2 		$158M Buy
2,047,710
+750,811
+58% +$55M 1.37% 11
2024
Q1 		$88.8M Buy
+1,296,899
New +$83.4M 0.81% 34
2023
Q3 		– Sell
-1,450,972
Closed -$78.5M – 245
2023
Q2 		$78.5M Buy
1,450,972
+1,029,864
+245% +$53.8M 0.81% 45
2023
Q1 		$21.1M Buy
+421,108
New +$19.8M 0.26% 99
2019
Q4 		– Sell
-301,609
Closed -$12.3M – 260
2019
Q3 		$12.3M Sell
301,609
-32,021
-10% -$1.36M 0.23% 109
2019
Q2 		$14.3M Sell
333,630
-132,875
-28% -$5.11M 0.28% 89
2019
Q1 		$17.9M Buy
466,505
+73,857
+19% +$2.82M 0.38% 69
2018
Q4 		$13.9M Sell
392,648
-36,967
-9% -$1.34M 0.33% 90
2018
Q3 		$16.5M Sell
429,615
-187,493
-30% -$6.55M 0.35% 80
2018
Q2 		$20.2M Buy
617,108
+401,915
+187% +$12.1M 0.46% 50
2018
Q1 		$5.88M Sell
215,193
-109,033
-34% -$2.96M 0.14% 210
2017
Q4 		$8.04M Sell
324,226
-22,409
-6% -$618K 0.19% 121
2017
Q3 		$10.1M Sell
346,635
-1,136
-0.3% -$31.4K 0.28% 85
2017
Q2 		$9.64M Buy
347,771
+142,661
+70% +$3.79M 0.27% 81
2017
Q1 		$5.1M Sell
205,110
-64,371
-24% -$1.57M 0.15% 170
2016
Q4 		$5.83M Sell
269,481
-205,739
-43% -$4.49M 0.18% 135
2016
Q3 		$11.3M Sell
475,220
-46,149
-9% -$1.1M 0.38% 68
2016
Q2 		$12.2M Sell
521,369
-161,561
-24% -$3.5M 0.43% 60
2016
Q1 		$12.8M Buy
682,930
+236,358
+53% +$4.15M 0.46% 55
2015
Q4 		$8.23M Buy
+446,572
New +$8M 0.3% 102

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Zurich Insurance Group's BSX Position: Q2 2026 in Review

Zurich Insurance Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 272,168 shares — an estimated $17.1M sold.

Zurich Insurance Group first reported a position in BSX in Q4 2015 and held it in 25 quarters. The position peaked at $158M in Q2 2024. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Zurich Insurance Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Zurich Insurance Group sold 272,168 Boston Scientific shares in Q2 2026, an estimated $17.1M.
  • Zurich Insurance Group first reported a position in Boston Scientific in Q4 2015 and held it in 25 quarters.
  • Zurich Insurance Group's Boston Scientific position peaked at $158M in Q2 2024.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Zurich Insurance Group's 13F filing for Q2 2026, filed 14 Aug 2026.